Chaogang Wang , Zeyu Hong , Mingjian Song , Hao Zheng , Qiaomian Zhou , Haihong Yang , Hui Li , Danqiong Huang
{"title":"Production of astaxanthin with high purity and activity based on engineering improvement strategies","authors":"Chaogang Wang , Zeyu Hong , Mingjian Song , Hao Zheng , Qiaomian Zhou , Haihong Yang , Hui Li , Danqiong Huang","doi":"10.1016/j.jbiotec.2025.05.012","DOIUrl":null,"url":null,"abstract":"<div><div>Here, astaxanthin production in <em>Escherichia coli</em> was systematically improved step by step. By introducing the additional copy of <em>CrtZ</em> and fusion complex of <em>CrtZ</em> and <em>CrtW</em>, astaxanthin content in cells increased from 0.10 mg/g to 0.16 mg/g and 0.63 mg/g DCW, respectively. Remolding the astaxanthin gene cluster by replacing the <em>PanCrtE</em> by <em>HpGGPPS3–1</em> and the fusion of <em>CrtZ</em> and <em>CrtW</em> increased astaxanthin content to 1.98 mg/g DCW. Further selecting the productive host and optimizing culture conditions dramatically increased astaxanthin content to 3.61 mg/g DCW. Subsequently, the fed-batch fermentation achieved the maximum yield of astaxanthin at 509.58 mg/L with the productivity of 7.72 mg/L/h and 5.91 mg/g DCW, covering 98.17 % of detected carotenoids. The chirality analysis assigned the same isomer of astaxanthin extracted from our fermentation system and <em>Haematococcus pluvialis</em>. Moreover, the radical and superoxide anion scavenging activity analysis revealed that astaxanthin achieved in this study performed better than natural astaxanthin extracted from <em>H. pluvialis</em> and chemical synthetic astaxanthin. This study provides a step-by-step example for bioengineering improvement of natural products in <em>E. coli</em> with high purity and activity.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"405 ","pages":"Pages 139-149"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016816562500135X","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Here, astaxanthin production in Escherichia coli was systematically improved step by step. By introducing the additional copy of CrtZ and fusion complex of CrtZ and CrtW, astaxanthin content in cells increased from 0.10 mg/g to 0.16 mg/g and 0.63 mg/g DCW, respectively. Remolding the astaxanthin gene cluster by replacing the PanCrtE by HpGGPPS3–1 and the fusion of CrtZ and CrtW increased astaxanthin content to 1.98 mg/g DCW. Further selecting the productive host and optimizing culture conditions dramatically increased astaxanthin content to 3.61 mg/g DCW. Subsequently, the fed-batch fermentation achieved the maximum yield of astaxanthin at 509.58 mg/L with the productivity of 7.72 mg/L/h and 5.91 mg/g DCW, covering 98.17 % of detected carotenoids. The chirality analysis assigned the same isomer of astaxanthin extracted from our fermentation system and Haematococcus pluvialis. Moreover, the radical and superoxide anion scavenging activity analysis revealed that astaxanthin achieved in this study performed better than natural astaxanthin extracted from H. pluvialis and chemical synthetic astaxanthin. This study provides a step-by-step example for bioengineering improvement of natural products in E. coli with high purity and activity.
期刊介绍:
The Journal of Biotechnology has an open access mirror journal, the Journal of Biotechnology: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
The Journal provides a medium for the rapid publication of both full-length articles and short communications on novel and innovative aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case the material is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome.